Although numerous studies have examined the clinical implications of single heterozygous mutations in GJB2 on SNHL, there is no consensus regarding the interpretation of the results when one mutation is identified in the GJB2 gene of the subject. The gene discussed is GJB2; the disease is sensorineural hearing loss disorder.